The five nonsynonymous mutations with previous disease association were not predicted to be deleterious but, interestingly, m.6489C > A (p.L196I, MTCO1) has been reported to be associated with therapy-resistant epilepsy [41]. This evidence concerns the gene MT-CO1 and epilepsy.